Automated blood analysis company, Scopio Labs, secures an additional $10 million in funding for advancements in blood morphology automation technology.

Scopio Labs Introduces AI-Powered Complete Blood Morphology (CBM) Analyzer to Automate Manual Diagnostic Processes in Laboratories